Clinical Trial Update: Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update notes SENTOV II evaluating the sentinel lymph node technique in early-stage ovarian cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Ovarian Neoplasms | Phase 3 | Status: RECRUITING